Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
AIDS Research and Human Retroviruses
|
March 13, 2020
Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366
Karine Dubé, Lara Hosey, Kate Starr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 16, 2022
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282
Timothy Wilkin, Huichao Chen, Vikrant Sahasrabuddhe, et al.
The Journal of Infectious Diseases
|
February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
Timothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
The Journal of Antimicrobial Chemotherapy
|
January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353
Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
The Lancet. HIV
|
September 10, 2019
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study
Kimberly K Scarsi, Yoninah S Cramer, Susan L Rosenkranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings
Carole L Wallis, Michael D Hughes, Justin Ritz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 24, 2019
Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART
Roger J Bedimo, Hanna Mar, Ronald J Bosch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2019
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency
Rosie Mngqibisa, Michelle A Kendall, Kelly Dooley, et al.
Cell Reports. Medicine
|
September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV
Timothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.
Contraception
|
January 14, 2023
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens
Kimberly K Scarsi, Laura M Smeaton, Anthony T Podany, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
AIDS Research and Human Retroviruses
|
March 13, 2020
Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366
Karine Dubé, Lara Hosey, Kate Starr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 16, 2022
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282
Timothy Wilkin, Huichao Chen, Vikrant Sahasrabuddhe, et al.
The Journal of Infectious Diseases
|
February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
Timothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
The Journal of Antimicrobial Chemotherapy
|
January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353
Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
The Lancet. HIV
|
September 10, 2019
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study
Kimberly K Scarsi, Yoninah S Cramer, Susan L Rosenkranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings
Carole L Wallis, Michael D Hughes, Justin Ritz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 24, 2019
Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART
Roger J Bedimo, Hanna Mar, Ronald J Bosch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2019
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency
Rosie Mngqibisa, Michelle A Kendall, Kelly Dooley, et al.
Cell Reports. Medicine
|
September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV
Timothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.
Contraception
|
January 14, 2023
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens
Kimberly K Scarsi, Laura M Smeaton, Anthony T Podany, et al.
Page
of 11